The AVITHRAPID consortium "Antiviral Therapeutics for Rapid Response Against Pandemic Infectious Diseases" is part of the Horizon Europe Framework Programme and consists of 18 participants and partners from 8 countries.
Project
Description
Outcome &
Deliverables
Research
Repositories
Latest News & Events from AVITHRAPID
Breaking News: AVITHRAPID Publishes Key Data to Accelerate Drug Development for Dengue
Breaking News: AVITHRAPID Publishes Key Data to Accelerate Drug Development for Dengue AVITHRAPID has announced a breakthrough in the fight against dengue fever by publishing critical protein models for all four dengue virus (DENV) serotypes. These open-access data represent a transformative step
Press Announcement: AVITHRAPID at the International Conference on Pandemic Preparedness in Trieste
Trieste, Italy – The AVITHRAPID project is excited to participate in the upcoming International Conference titled “Pandemic Preparedness: Achievements, Current Challenges, and New Frontiers” from 11 November 2024 at the prestigious Savoia Excelsior Palace in Trieste, Italy. Organized by Area Science Park
The ARCA Factory event
Francesca Incardona of EuResist network, member of Avithrapid consortium, was in Bologna to explore international collaborations at a 2 days workshop for infectious diseases specialists and virologists: the ARCA (Antiretroviral Resistance Cohort Analysis) Factory event (Bologna 30 Sept-1 October).ARCA Factory (https://www.informapro.it/arca.html) is